Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebellar mutism.

Mehmet Turgut

    Journal of Neurosurgery. Pediatrics
    |March 21, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Cerebellar mutism syndrome (CMS) affects nearly a quarter of children after medulloblastoma resection, often severely. Brainstem invasion is a key risk factor for developing this postoperative syndrome.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.

    HemaSphere·2026
    Same author

    Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

    The New England journal of medicine·2026
    Same author

    Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUS.

    Blood advances·2026
    Same author

    Dynamic HALP Score as a Time-Dependent Prognostic Biomarker in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.

    Cancers·2026
    Same author

    Clinical performance of 3D-printed resin versus prefabricated zirconia crowns in primary molars: A split-mouth clinical study.

    Journal of dentistry·2026
    Same author

    Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.

    Leukemia research·2026
    Same journal

    Development of the superficial temporal artery in pediatric patients: considerations for surgical revascularization.

    Journal of neurosurgery. Pediatrics·2026
    Same journal

    Impact of handheld and wearable electronics on programmable shunt valves.

    Journal of neurosurgery. Pediatrics·2026
    Same journal

    Who are we training and where do they go? Trends in demographics in the pediatric neurosurgery workforce.

    Journal of neurosurgery. Pediatrics·2026
    Same journal

    The Supreme Court of New Jersey has done a disservice to victims of abusive head trauma.

    Journal of neurosurgery. Pediatrics·2026
    Same journal

    Correlation of noninvasive near-infrared spectroscopy with outcomes in pediatric traumatic brain injury.

    Journal of neurosurgery. Pediatrics·2026
    Same journal

    Comparison of outcomes after occipitocervical fusion in adult versus pediatric patients: the University of Oklahoma experience.

    Journal of neurosurgery. Pediatrics·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Neurosurgery
    • Neuroscience

    Background:

    • Cerebellar mutism syndrome (CMS) is a rare postoperative complication following midline posterior fossa tumor resection.
    • Previous studies on CMS were limited to small retrospective case series.

    Discussion:

    • This study prospectively surveyed 450 children with medulloblastoma across two large clinical trials.
    • CMS occurred in 24% of patients, with 92% experiencing moderate to severe symptoms.
    • Mutism and ataxia were the most frequent severe symptoms.

    Key Insights:

    • Preoperative brainstem invasion was the sole identified risk factor for CMS.
    • Tumor location in the cerebellar hemisphere showed a negative correlation with CMS risk.
    • A significant proportion of patients experienced persistent nonmotor speech/language deficits, neurocognitive deficits, or ataxia one year post-diagnosis.

    Related Experiment Videos

    Outlook:

    • As surgical resections for medulloblastoma become more aggressive, the risk of CMS-related morbidity must be carefully considered.
    • Prognostic factors, particularly brainstem invasion, should guide surgical decision-making to minimize CMS incidence.
    • Further research is needed to understand the underlying mechanisms and develop preventative strategies for CMS.